← Leaderboards
Eugen Brailoiu
Temple Univ Of The Commonwealth
$1,947,874
Attributed
$2,383,748
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $590K · FY2009–25$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,383,748 · 3
By mechanism
R01$1,512,000 · 1
R21$871,748 · 2
Top collaborators
- Saadet Inan2 shared
- Sara J. Ward2 shared
Most similar at Temple Univ Of The Commonwealth
Same institution · by research overlap
- Allison Michelle Andrews$4,229,979
- Khalid Benamar$3,625,175
- Saadet Inan$217,937
- Scott M Rawls$11,077,907
Others in their field
Top investigators on “Neurons”
- Hongkui Zeng · Allen Institute$106,358,289
- Eric Martin McDade · Washington University$94,632,845
- Ed Lein · Allen Institute$90,858,363
- Randall J Bateman · Washington University$65,841,935
- John Morris · Washington University$65,018,684
- Paul S. Aisen · Cognition Therapeutics, Inc.$58,570,460
Research focus
NeuronsIn VivoMeasurementSignal TransductionImageInterdisciplinary ApproachMediatingPathway InteractionsResponseAgonistExtracellularIn VitroCellsHeartConjugated Equine EstrogensHeart RateCholinergic NeuronEstrogensHormone Replacement TherapyCalciumCardiovascular SystemEstradiolBrain StemBradycardia
Grant awards (9)
Deciphering the complex pharmacology of kappa opioid receptor: Towards the understanding of a third signaling pathway and its essential role in antipruritic effect$198,124
R21 · FY2025 · DA
Deciphering the complex pharmacology of kappa opioid receptor: Towards the understanding of a third signaling pathway and its essential role in antipruritic effect$237,749
R21 · FY2024 · DA
Deciphering the complex pharmacology of CB1: towards the understanding of a third signaling pathway$198,125
R21 · FY2024 · DA · contact PI
Deciphering the complex pharmacology of CB1: towards the understanding of a third signaling pathway$237,750
R21 · FY2023 · DA · contact PI
Role of nonnuclear estrogen receptor GPR30 in preganglionic vagal neurons$297,000
R01 · FY2012 · HL · contact PI
Role of nonnuclear estrogen receptor GPR30 in preganglionic vagal neurons$300,000
R01 · FY2011 · HL · contact PI
Role of nonnuclear estrogen receptor GPR30 in preganglionic vagal neurons$325,000
R01 · FY2010 · HL · contact PI
Role of nonnuclear estrogen receptor GPR30 in preganglionic vagal neurons$350,000
R01 · FY2009 · HL · contact PI
Role of nonnuclear estrogen receptor GPR30 in preganglionic vagal neurons$240,000
R01 · FY2009 · HL · contact PI